Atezolizumab + Bevacizumab
Treatment used for 4 conditions
Total Trials
77
Total Participants
17K
Avg Effectiveness
79%
Avg Safety Score
40%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Liver cancer due to hepatitis C
Effectiveness:78%
Safety:45%
Trials:50
Participants:10K
Liver cancer due to NASH
Effectiveness:88%
Safety:35%
Trials:10
Participants:3K
Liver cancer due to alcohol use
Effectiveness:65%
Safety:50%
Trials:10
Participants:2K
Liver cancer due to hepatitis B
Effectiveness:85%
Safety:30%
Trials:7
Participants:2K